Search by Practice
Insights & News / Rahaf Awawdi
Inven Capital Co-Leads Wint’s Funding Round
We are proud to have advised Inven Capital, which co-led Wint’s funding round. Wint develops technology for the early detection of water waste and the prevention of costly water damage. Ariella Dreyfuss and Rahaf Awawdi of our firm advised Inven Capital throughout the transaction.
Singapore-Based Prytek Acquires TipRanks at USD 200 Million Valuation
Advs. Ariella Dreyfuss and Rahaf Awawdi represented TipRanks in a transaction whereby Prytek acquired an additional 40% stake in TipTanks, becoming its controlling shareholder. In 2021, TipRanks raised USD 77 million, partially through a secondary offering led by Prytek. This transaction was also handled by the firm, with Adv. Hanna Daher assisting in all tax aspects.
Barnea: Representing Thermo Fisher in its Investment in CytoReason
Our firm represents Thermo Fisher in its participation in an $80 million financing round for CytoReason, alongside notable investors OurCrowd, Nvidia, and Pfizer. CytoReason offers therapeutic leaders molecular-level insights and advanced AI tools to support data-driven decision-making in healthcare and life sciences. Representing Thermo Fisher in this transaction are lawyers Simon Jaffa, Ariella Dreyfuss and Rahaf Awawdi .
The Profit Test for Dividend Distribution – Israeli Supreme Court Ruling
In a precedential ruling, the Supreme Court stated that the profit test for dividend distribution only includes an examination of the financial statements from the last two years. According to the ruling, there is no room to take into account information regarding an expected loss that has not yet appeared in the reports.